The biotechnology company ranks fourth on the short squeeze leaderboard, moving up 30 positions. Data shows 19.1% of the float short and a cost to borrow of 556.4%. The cost to borrow is the highest ...
The stock ranks fourth on the Fintel short squeeze leaderboard, moving up three positions. Data shows 8.1% of the float short and a cost to borrow of 394.8%. The company saw shares fall after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results